Redesigning Cardiac Surgery to Reduce Neurologic Injury

NCT00432536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 469

Last updated 2013-05-16

No results posted yet for this study

Summary

Neurologic injuries are frequent and devastating complications following cardiac surgery. Previous work conducted by our research group and others has identified the principal mechanisms creating both overt and subtle neurologic injuries after cardiac surgery. Current work by our group has identified that the causes (thrombotic/lipid emboli, cerebral hypoperfusion \& hypotension, and gaseous emboli) of these injuries are byproducts of processes of surgical and perfusion care. This insight suggests that the redesign of clinical strategies and techniques to prevent the occurrence of these intraoperative sources of damage may provide an opportunity to reduce the risk of neurologic injury after cardiac surgery.

The goal of this research is to identify modifiable clinical strategies and techniques of surgical and perfusion care associated with the causes (thrombotic/lipid emboli, cerebral hypoperfusion \& hypotension, and gaseous emboli) of neurologic injury secondary to coronary artery bypass graft (CABG) surgery, and subsequently to redesign these processes to reduce a patient's risk of a neurologic injury.

Conditions

Interventions

OTHER

Quality improvement intervention

determine the effectiveness of adopting quality improvement strategies to reduce embolization, hypotension and cerebral desaturation

Sponsors & Collaborators

  • MaineHealth

    collaborator OTHER
  • Catholic Medical Center

    collaborator OTHER
  • Somanetics Corporation

    collaborator INDUSTRY
  • LivaNova

    collaborator INDUSTRY
  • Maquet Cardiovascular

    collaborator INDUSTRY
  • Northern New England Cardiovascular Disease Study Group

    collaborator UNKNOWN
  • Luna Innovations

    collaborator INDUSTRY
  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED
  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Donald S Likosky, Ph.D. · Dartmouth-Hitchcock Medical Center

  • David J. Malenka, MD · Dartmouth-Hitchcock Medical Center

Eligibility

Min Age
40 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2011-08-31
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00432536 on ClinicalTrials.gov